Patent foramen ovale-related complications in left ventricular assist device patients: a reappraisal for cardiovascular professionals.


Journal

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
ISSN: 1619-0904
Titre abrégé: J Artif Organs
Pays: Japan
ID NLM: 9815648

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 05 2019
accepted: 21 08 2019
pubmed: 30 8 2019
medline: 31 10 2020
entrez: 30 8 2019
Statut: ppublish

Résumé

Left ventricular assist device (LVAD) implantation is an important treatment option for patients with advanced heart failure. The presence of a patent foramen ovale (PFO) may elicit undesired consequences in LVAD patients: hypoxemia and paradoxical embolization. The variable physiological status of the patient with heart failure can make pre-LVAD implant identification of a PFO elusive. When identified pre- or intraoperatively, PFO is closed at time of LVAD implantation. In the case of delayed diagnosis, percutaneous PFO closure has proven to be a feasible and safe solution. As mechanical circulatory support gains prevalence, it is important to raise awareness of physiological implications of right-to-left shunt during mechanical circulatory support. We reviewed the diagnostic and therapeutic management of PFO in LVAD patients.

Identifiants

pubmed: 31463532
doi: 10.1007/s10047-019-01128-0
pii: 10.1007/s10047-019-01128-0
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-104

Auteurs

Daniela Bacich (D)

Department of Cardiology, Madonna Della Salute Hospital, via Badaloni 25, Porto Viro, Rovigo, Italy. danielabacich73@gmail.com.

Andrea Fiorencis (A)

Department of Cardiology, Madonna Della Salute Hospital, via Badaloni 25, Porto Viro, Rovigo, Italy.

Gabriele Braggion (G)

Division of Cardiology, Adria General Hospital, Rovigo, Italy.

Marco Zuin (M)

Section of Adult Congenital and Adult Heart Disease, Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy.

Gianluca Rigatelli (G)

Section of Adult Congenital and Adult Heart Disease, Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy. jackyheart@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH